By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ferring Pharmaceuticals 

Avenue de Rhodanie 60

Lausanne    CH 1007  Switzerland
Phone: 41-21-614-2772 Fax: 41-21-614-2773



Company News
Ferring Pharma Announces Approval For NOCDURNA, A New Therapeutic Option For The Treatment Of Adults Waking Multiple Times To Urinate At Night 5/3/2016 9:29:29 AM
Ferring Pharma And National Style Expert Bobbie Thomas Launch The Fertility Facts: Know More. Start Asking. Campaign During National Infertility Awareness Week 4/25/2016 11:08:18 AM
Ferring Pharma Release: Couple's Inspiring Video On Overcoming Infertility, Fighting Cancer Wins Educational Grant 4/7/2016 10:38:27 AM
Ferring Pharma: Wake Up To Nocturia: The Most Common Cause Of Disrupted Sleep That Could Be Damaging Your Health 3/18/2016 10:36:41 AM
Ferring Pharma Names Aaron Graff As Chief Executive Officer Of U.S. Holding Company 3/1/2016 11:01:25 AM
Ferring Pharmaceuticals Announces The Start Of The PRONOUNCE Trial For Patients With Advanced Prostate Cancer And Cardiovascular Disease Receiving Degarelix Or Leuprolide 2/8/2016 10:48:19 AM
Ferring Pharmaceuticals And Karolinska Institute Sign Collaboration Agreement On The Development Of A Human Microbiome Translational Research Programme 1/27/2016 10:11:34 AM
Ferring Pharmaceuticals Named As National Sponsor Of Arthritis Foundation Fundraising Events 11/10/2015 10:32:14 AM
Ferring Pharmaceuticals Receives Acceptance Of Marketing Authorisation Filing From European Medicines Agency For Personalised Fertility Treatment With REKOVELLE (Follitropin Delta) 10/30/2015 10:30:10 AM
Apricus Biosciences (APRI) And Ferring Pharmaceuticals Sign Exclusive Distribution Agreement To Market Topical Erectile Dysfunction Cream Vitaros In Latin American Countries 10/1/2015 7:37:44 AM